BE847368A - Nouvelles compositions pharmaceutiques et leur preparation, - Google Patents

Nouvelles compositions pharmaceutiques et leur preparation,

Info

Publication number
BE847368A
BE847368A BE171578A BE171578A BE847368A BE 847368 A BE847368 A BE 847368A BE 171578 A BE171578 A BE 171578A BE 171578 A BE171578 A BE 171578A BE 847368 A BE847368 A BE 847368A
Authority
BE
Belgium
Prior art keywords
preparation
pharmaceutical compositions
new pharmaceutical
new
compositions
Prior art date
Application number
BE171578A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE847368A publication Critical patent/BE847368A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
BE171578A 1975-10-17 1976-10-15 Nouvelles compositions pharmaceutiques et leur preparation, BE847368A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (1)

Publication Number Publication Date
BE847368A true BE847368A (fr) 1977-04-15

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
BE171578A BE847368A (fr) 1975-10-17 1976-10-15 Nouvelles compositions pharmaceutiques et leur preparation,

Country Status (28)

Country Link
JP (1) JPS5854122B2 (fr)
AT (1) AT362510B (fr)
AU (1) AU508628B2 (fr)
BE (1) BE847368A (fr)
CA (1) CA1079641A (fr)
CH (1) CH643737A5 (fr)
CS (1) CS199647B2 (fr)
DE (1) DE2546577B2 (fr)
DK (1) DK146194C (fr)
ES (1) ES452420A1 (fr)
FI (1) FI762875A (fr)
FR (1) FR2327764A1 (fr)
GB (1) GB1560406A (fr)
GR (1) GR61268B (fr)
HK (1) HK3183A (fr)
HU (1) HU172533B (fr)
IE (1) IE43778B1 (fr)
IL (1) IL50686A (fr)
MY (1) MY8400063A (fr)
NL (1) NL184558C (fr)
NO (1) NO144468C (fr)
NZ (1) NZ182341A (fr)
PH (1) PH14513A (fr)
PT (1) PT65719B (fr)
SE (1) SE430379B (fr)
SG (1) SG63082G (fr)
SU (1) SU1165223A3 (fr)
ZA (1) ZA766166B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
EP0277092B1 (fr) * 1987-01-14 1992-01-29 Ciba-Geigy Ag Système thérapeutique pour médicaments peu solubles
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (de) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimal freisetzende Kava-Extrakte
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
PL192423B1 (pl) * 1997-12-22 2006-10-31 Schering Corp Kompozycja farmaceutyczna typu molekularnej dyspersji
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
AU2165301A (en) * 1999-12-03 2001-06-12 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
PT1638527E (pt) * 2003-06-27 2007-02-28 Bioprogress Spa Produto compósito obtido por co-trituração de um princípio activo com um copolímero de n-vinil-2-pirrolidona/acetato de vinilo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
IL50686A (en) 1979-05-31
NO763446L (fr) 1977-04-19
NL184558B (nl) 1989-04-03
PT65719B (fr) 1978-06-12
NL7611295A (nl) 1977-04-19
NL184558C (nl) 1989-09-01
IE43778B1 (en) 1981-05-20
HU172533B (hu) 1978-09-28
JPS5854122B2 (ja) 1983-12-02
GB1560406A (en) 1980-02-06
FR2327764A1 (fr) 1977-05-13
CH643737A5 (en) 1984-06-29
IL50686A0 (en) 1976-12-31
PH14513A (en) 1981-08-24
GR61268B (en) 1978-10-17
AT362510B (de) 1981-05-25
MY8400063A (en) 1984-12-31
JPS5251014A (en) 1977-04-23
DK454176A (da) 1977-04-18
FR2327764B1 (fr) 1979-03-02
FI762875A (fr) 1977-04-18
SU1165223A3 (ru) 1985-06-30
DK146194C (da) 1984-01-02
HK3183A (en) 1983-01-20
PT65719A (fr) 1976-11-01
SE430379B (sv) 1983-11-14
SG63082G (en) 1983-09-09
IE43778L (en) 1977-04-17
NO144468B (no) 1981-06-01
DE2546577A1 (de) 1977-04-21
ZA766166B (en) 1978-05-30
ES452420A1 (es) 1978-04-16
ATA767976A (de) 1980-10-15
SE7611189L (sv) 1977-04-18
CA1079641A (fr) 1980-06-17
DK146194B (da) 1983-07-25
AU508628B2 (en) 1980-03-27
DE2546577B2 (de) 1981-04-02
NO144468C (no) 1981-09-09
AU1875476A (en) 1978-04-20
CS199647B2 (en) 1980-07-31
NZ182341A (en) 1978-09-20

Similar Documents

Publication Publication Date Title
FR2276832A1 (fr) Nouvelles compositions pharmaceutiques et leur preparation
BE839615A (fr) Nouvelles amidinourees, leur preparation et leur emploi
BE810197A (fr) Nouvelles electrodes et leur preparation
BE847368A (fr) Nouvelles compositions pharmaceutiques et leur preparation,
BE833044A (fr) 4-arylpiperidines 1, 3, 4 -trisubtituees et leur preparation
BE853422A (fr) Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant
BE843152A (fr) Nouvelles cephalosporimes, leur preparation et leur emploi
FR2320745A1 (fr) Nouveaux agents anti-flammatoires imidazoles, leur preparation et compositions pharmaceutiques
BE829082A (fr) Nouvelles diamines, leur preparation et leur application
BE847165A (fr) Nouvelles compositions detergentes et leur preparation,
FR2283689A1 (fr) Nouvelles cephamycines, leur preparation et leur application
FR2290193A1 (fr) Derives de n2-naphtalenesulfonyl-l-arginine, leur preparation et compositions pharmaceutiques les contenant
FR2340310A1 (fr) Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant
FR2310132A1 (fr) 14b-hydroxy-3-desoxycardenolides et analogues de ceux-ci, leur preparation et compositions pharmaceutiques les contenant
FR2276833A1 (fr) Nouvelles compositions galeniques et leur preparation
FR2313059A1 (fr) Nouvelles solutions pharmaceutiques stables et leur preparation
FR2318174A1 (fr) Diepoxy-androstanes et leur preparation
BE820256A (fr) Nouvelles phenoxyalkylamines et leur preparation
BE840608A (fr) Nouvelles compositions pharmaceutiques
BE826925A (fr) Nouvelles pyrrolodiazepines et leur preparation
IL50090A0 (en) New quinolines,their preparation and pharmaceutical compositions containing them
FR2322594A1 (fr) Nouvelles 2,3-trans-methylene-15-hydroxy-prostaglandines, leur preparation et leur application comme medicaments
FR2315275A1 (fr) 1-acyl-1,2,3,4-tetrahydro-6-quinoleinols et leur preparation
FR2303545A1 (fr) Nouvelles pyridones, leur preparation et leur application comme medicaments
FR2287220A1 (fr) Nouvelles compositions pharmaceutiques anti-inflammatoires et leur procede de preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19911031